News & Insights

Subscribe

  • People
  • Offices
    • back
    • Offices
    • North America
      • back
      • North America
      • Atlanta
      • Austin
      • Charlotte
      • Chicago
      • Denver
      • Houston
      • Los Angeles
      • Miami
      • New York
      • Northern Virginia
      • San Francisco
      • Silicon Valley
      • Washington, D.C.
    • Europe & Middle East
      • back
      • Europe & Middle East
      • Abu Dhabi
      • Brussels
      • Dubai
      • Frankfurt
      • Geneva
      • London
      • Paris
      • Riyadh
    • Asia
      • back
      • Asia
      • Singapore
      • Tokyo
  • Capabilities
    • back
    • Capabilities
    • Corporate, Finance and Investments
      • back
      • Corporate, Finance and Investments
      • Overview
      • Activist Defense
      • Banking and Institutional Finance
      • Capital Markets
      • Construction and Procurement
      • Corporate Governance
      • Emerging Companies and Venture Capital
      • Employee Benefits and Executive Compensation
      • Energy and Infrastructure Projects
      • Financial Restructuring
      • Global Human Capital and Compliance
      • Investment Funds and Asset Management
      • Mergers and Acquisitions (M&A)
      • Middle East and Islamic Finance and Investment
      • Private Credit & Special Situations
      • Private Equity
      • Public Companies
      • Real Estate
      • Structured Finance and Securitization
      • Tax
      • Technology Transactions
    • Government Matters
      • back
      • Government Matters
      • Overview
      • Antitrust
      • Data, Privacy and Security
      • Environmental, Health and Safety
      • FDA and Life Sciences
      • Government Advocacy and Public Policy
      • Government Contracts
      • Healthcare
      • International Trade
      • National Security and Corporate Espionage
      • Securities Enforcement and Regulation
      • Special Matters and Government Investigations
    • Trial and Global Disputes
      • back
      • Trial and Global Disputes
      • Overview
      • Antitrust
      • Appellate, Constitutional and Administrative Law
      • Bankruptcy and Insolvency Litigation
      • Class Action Defense
      • Commercial Litigation
      • Construction and Engineering Disputes
      • Corporate and Securities Litigation
      • E-Discovery
      • Intellectual Property
      • International Arbitration and Litigation
      • Labor and Employment
      • Product Liability
      • Professional Liability
      • Toxic & Environmental Torts
    • Industries / Issues
      • back
      • Industries / Issues
      • Industries
      • Automotive, Transportation and Mobility
      • Energy Transition
      • Energy
      • Financial Services
      • Food and Beverage
      • Higher Education
      • Life Sciences and Healthcare
      • Technology
      • Issues
      • #MeToo
      • Artificial Intelligence and Machine Learning
      • Buy American
      • Crisis Management
      • Doing Business in Latin America
      • Environmental Agenda
      • Environmental, Social and Governance (ESG)
      • Focus on Women's Health
      • Russia/Ukraine
      • Special Purpose Acquisition Companies (SPACs)
  • Careers
    • back
    • Careers
    • Lawyers
      • back
      • Lawyers
      • Experienced Lawyers
    • Students
      • back
      • Students
      • Law Students
      • UK Graduate Recruitment
    • Judicial Clerks
      • back
      • Judicial Clerks
      • Judicial Clerks
    • Other Professionals
      • back
      • Other Professionals
      • Other Professionals
  • News & Insights
    • back
    • News & Insights
    • News
      • back
      • News
      • All News
      • Cases & Deals
      • In the News
      • Press Releases
      • Recognitions
    • Events
      • back
      • Events
      • All Events
      • Conferences
      • Speaking Engagements
      • Webinars
    • Insights
      • back
      • Insights
      • All Insights
      • Newsletters
      • Client Alerts
      • Thought Leadership
      • Articles
      • Feature
      • BLOGS
      • Auditor Liability Bulletin
      • ESG Excellence
  • About
    • back
    • About
    • Our Firm
      • back
      • Our Firm
      • History
      • Our Values
    • Diversity & Inclusion
      • back
      • Diversity & Inclusion
      • Overview
      • Women’s Initiatives
      • Racial Diversity
      • LBGTQ+ Affinity
    • Citizenship
      • back
      • Citizenship
      • Overview
      • Pro Bono
      • Community Focus
  • Languages

News & Insights

  • News
    • back
    • News
    • All News
    • Cases & Deals
    • In the News
    • Press Releases
    • Recognitions
  • Events
    • back
    • Events
    • All Events
    • Conferences
    • Speaking Engagements
    • Webinars
  • Insights
    • back
    • Insights
    • All Insights
    • Newsletters
    • Client Alerts
    • Thought Leadership
    • Articles
    • Feature
    • BLOGS
    • Auditor Liability Bulletin
    • ESG Excellence
< Back to Bio
Christina M. Markus (Chris)
Calendar view

Events 27 results

Webinar

September 27, 2023
At Last! FDA Issues Final Guidance on Use of Real-World Evidence for Regulatory Decision-Making for Drug and Biological Products

Conference

September 7, 2023
16th Annual King & Spalding Medical Device Summit

Webinar

April 20, 2023
Revision of the EU Pharmaceutical Legislation - What To Expect

Conference

March 8, 2023
California Life Sciences Summit

Webinar

November 30, 2022
Are You Prepared? FDA’s Proposed Rules to Modify Protection of Human Subjects and IRB Oversight

Conference

November 1, 2022
Pharmaceutical University 2022

Webinar

September 21, 2022
Regulation of Cell and Gene Therapies – Part 2: EU Law

Webinar

July 28, 2022
The Drug Supply Chain Security Act – Are Your Operations Ready for Final Implementation?

Speaking Engagement

March 16, 2022
Eva Temkin, Chris Markus to Speak at Food and Drug Law Institute’s Conference About Biological Products

Webinar

November 9, 2021
King & Spalding Pharmaceutical University 2021

Webinar

September 9, 2021
14th Annual King & Spalding Medical Device Summit

Webinar

June 15, 2021
Real-World Evidence: The Evolving Landscape for FDA and EU Decision-Making About Drugs, Biologics, and Medical Devices

© 2023 King & Spalding LLP
  • Contact Us
  • Disclaimer
  • Privacy Notice
  • Transparency Disclosure
  • Cookie Policy
  • Copyright Notice
  • Regulatory Notices
  • CPRA Privacy Notice
  • K&S Alumni Group